↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

68 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abp 959   -   -   -   -   1件:
62 
 2   Abp 959 - biosimilar to eculizumab   Eculizumab   D03940   1件: C5   1件: Complement and coagulation cascades   1件:
62 
 3   Ach-0144471   -   -   -   -   3件:
62,
222,
223 
 4   Aln-62643   -   -   -   -   1件:
62 
 5   Aln-cc5   -   -   -   -   2件:
62,
109 
 6   Alxn1102   -   -   -   -   1件:
62 
 7   Alxn1103   -   -   -   -   1件:
62 
 8   Alxn1210   -   -   -   -   2件:
62,
109 
 9   Anti-c5 antibody   -   -   -   -   4件:
11,
14,
62,
109 
 10   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 11   Apl-2   -   -   -   -   5件:
61,
62,
66,
222,
223 
 12   Bcd-148   -   -   -   -   1件:
62 
 13   Bryostatin 1   Bryostatin 1   -   -   -   1件:
62 
 14   C5 inh mab, sky59, ro/ch7092230   -   -   -   -   1件:
62 
 15   Campath, chemo and/or tbi allo sct   -   -   -   -   3件:
60,
62,
283 
 16   Coversin   Nomacopan   D11473   1件: C5   2件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction   2件:
62,
109 
 17   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 18   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 19   Cyclosporin a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   11件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
113,
164 
 20   Cyclosporin a+glucocorticoids   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
60,
62 
 21   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 22   Cytoreductive regimen followed by a cd34+e- selected allogeneic stem cell transplant   -   -   -   -   1件:
62 
 23   Dextran   Dextran   D00060   -   -   5件:
2,
62,
79,
96,
97 
 24   Eculizumab   Eculizumab   D03940   1件: C5   1件: Complement and coagulation cascades   7件:
11,
13,
14,
62,
109,
222,
223 
 25   Fc- and cdr-modified humanised monoclonal antibody against c5   -   -   -   -   2件:
62,
109 
 26   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 27   Fludarabine   Fludarabine   D01907, D07966   1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 28   Fludarabine phosphate   Fludarabine, Phosphate ion   D01907, D07966   1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   11件:
28,
36,
49,
51,
60,
62,
65,
96,
283,
284,
285 
 29   Glucocorticoids   -   -   -   -   6件:
40,
41,
43,
44,
60,
62 
 30   Human monoclonal antibody directed against complement 5 protein   -   -   -   -   1件:
62 
 31   Iron   Docusate   D00305   -   -   7件:
13,
62,
86,
96,
97,
254,
284 
 32   Iron dextran   Dextran, Docusate, Iron Dextran   D00060, D00305, D02141   -   -   1件:
62 
 33   Iron sucrose   Docusate, Iron saccharate, Sucrose   D00025, D00305   -   -   3件:
62,
96,
97 
 34   Levamisole   Levamisole   D00750, D08114   -   -   3件:
60,
61,
62 
 35   Levamisole+cyclosporin a+glucocorticoids   Ciclosporin, Levamisole   D00184, D00750, D08114   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
60,
62 
 36   Lfg316   -   -   -   -   1件:
62 
 37   Lnp023   -   -   -   -   3件:
62,
66,
222 
 38   Melphalan   Melphalan   D00369   -   -   14件:
11,
13,
14,
19,
20,
28,
60,
62,
65,
96,
164,
234,
284,
285 
 39   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 40   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 41   Mycophenolate mofetil   Mycophenolic acid, Mycophenolate mofetil, mycophenolate mofetil   D00752, D05094, D05095, D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 42   Myeloablative preparative regimen   -   -   -   -   3件:
62,
65,
284 
 43   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 44   Ra101495   -   -   -   -   1件:
62 
 45   Ra101495 sodium   -   -   -   -   1件:
62 
 46   Ravulizumab   Ravulizumab   D11054   1件: C5   1件: Complement and coagulation cascades   3件:
11,
62,
109 
 47   Reduced intensity preparative regimen   -   -   -   -   3件:
62,
65,
284 
 48   Reduced toxicity ablative regimen   -   -   -   -   3件:
62,
65,
284 
 49   Regn3918   -   -   -   -   1件:
62 
 50   Ro7112689   -   -   -   -   1件:
62 
 51   Ro7112689/f01   -   -   -   -   1件:
62 
 52   Rva576   -   -   -   -   3件:
62,
109,
162 
 53   Rva576 (coversin)   Nomacopan   D11473   1件: C5   2件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction   2件:
62,
109 
 54   Sargramostim   Sargramostim   D05803   1件: CSF2RA   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer   6件:
6,
28,
60,
62,
96,
229 
 55   Sb12 (proposed eculizumab biosimilar)   Eculizumab   D03940   1件: C5   1件: Complement and coagulation cascades   1件:
62 
 56   Sirolimus   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 57   Soliris   Eculizumab   D03940   1件: C5   1件: Complement and coagulation cascades   7件:
11,
13,
14,
62,
109,
222,
223 
 58   Soliris (eculizumab)   Eculizumab   D03940   1件: C5   1件: Complement and coagulation cascades   1件:
62 
 59   Sterile normal saline (0.9% nacl)   -   -   -   -   3件:
62,
234,
254 
 60   Study drug - alxn1210   -   -   -   -   1件:
62 
 61   Sucrose   Sucrose   D00025   -   -   3件:
62,
96,
97 
 62   Synthetic 15-amino-acid macrocyclic peptide   -   -   -   -   1件:
62 
 63   Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker   -   -   -   -   1件:
62 
 64   Systematic chemotherapy and antibodies   -   -   -   -   1件:
62 
 65   Systemic chemotherapy and antibodies   -   -   -   -   2件:
62,
326 
 66   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 67   Zilucoplan (ra101495)   -   -   -   -   2件:
11,
62 
 68    lnp023 hydrochloride salt   -   -   -   -   2件:
62,
66 

先頭へ